Direxion Daily S&P Biotech Bull 3X ETF
LABU
19 hedge funds and large institutions have $15.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.14% less ownership
Funds ownership: 0.42% → 0.28% (-0.14%)
11% less call options, than puts
Call options by funds: $24.2M | Put options by funds: $27.1M
14% less funds holding
Funds holding: 22 → 19 (-3)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
61% less capital invested
Capital invested by funds: $40.7M → $15.9M (-$24.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$4.96M |
| 2 |
Jane Street
New York
|
+$4.34M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.64M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$1.02M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.14M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.78M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.06M |
| 4 |
HF
HRT Financial
New York
|
-$1.27M |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$1.07M |
LABU Hedge Fund Activity: Q1 2020 in Review
19 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2020, worth a combined $15.9M — down 61% from $40.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LABU and 5 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.
The largest buyer was Citigroup, adding an estimated $4.96M. The largest seller was Morgan Stanley, cutting an estimated $6.14M.
- 19 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2020, down from 22 in Q4 2019.
- Funds reported $15.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2020, down 61% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2020 and 6 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2020 was Citigroup, an estimated $4.96M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2020 was Morgan Stanley, an estimated $6.14M sold.
Based on aggregated 13F filings for Q1 2020.